1 paper4 findings
New/worsened sarcopenia
upin humans1HR 4.31
New/worsened sarcopenia is associated with first self-reported cancer in humans (HR 4.31, 95% CI 1.80–10.32).
HumansFour-level transition models in the pre-diagnostic risk set
Low muscle mass linked to later cancer reports in Chinese adults
Scientific reports8 Oct 2026
New/worsened low muscle mass
upin humans1HR 3.45
New/worsened low muscle mass is associated with first self-reported cancer in humans (HR 3.45, 95% CI 1.44–8.25).
HumansFour-level transition models in the pre-diagnostic risk set
Low muscle mass linked to later cancer reports in Chinese adults
Scientific reports8 Oct 2026
Sarcopenia
upin humans1HR 2.33
Sarcopenia is associated with first self-reported cancer in humans (HR 2.33, 95% CI 1.17–4.66).
HumansChinese adults without prior cancer reports in the pre-diagnostic risk set2015 muscle status preceding cancer reporting in 2018 or 2020
Low muscle mass linked to later cancer reports in Chinese adults
Scientific reports8 Oct 2026
Low muscle mass
upin humans1HR 2.02
Low muscle mass is associated with first self-reported cancer in humans (HR 2.02, 95% CI 1.10–3.71).
HumansChinese adults without prior cancer reports in the pre-diagnostic risk set2015 muscle status preceding cancer reporting in 2018 or 2020
Low muscle mass linked to later cancer reports in Chinese adults
Scientific reports8 Oct 2026
Compared with participants without low muscle mass, those with it had a hazard ratio of 2.02, indicating a higher rate of later self-reported cancer.Compared with participants without low muscle mass, those with it had a hazard ratio of 2.02, indicating a higher rate of later self-reported cancer.